title: A bit of sweetness for GVHD prevention.
abstract: In this issue of Blood, Parmar et al report on preclinical data suggesting that use of ex vivo fucosylated third-party human regulatory T cells (Tregs) could be an effective strategy for prevention of graft-versus-host disease (GVHD).
authors.affiliation: UNIVERSITÉ PIERRE ET MARIE CURIE; AND INSERM UNITÉ MIXTE DE RECHERCHE 938.
authors.forename: Mohamad
authors.identifier: http://orcid.org/0000-0002-7264-808X
authors.initials: M
authors.lastname: Mohty
authors.affiliation: UNIVERSITÉ PIERRE ET MARIE CURIE; AND INSERM UNITÉ MIXTE DE RECHERCHE 938.
authors.forename: Béatrice
authors.initials: B
authors.lastname: Gaugler
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D005260:Female; D005643:Fucose / Q000378:metabolism*; D006086:Graft vs Host Disease / Q000276:immunology* / Q000517:prevention & control*; D006801:Humans; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
chemical_list: D005643:Fucose